News Headline Summary

Amgen (AMGN) pleads guilty to misbranding charge

- Charge was on the misbranding of Anemia drug.

Reaction details (15:22)

- Co. shares are unmoved in reaction to the news; trades USD 89.19 last.

18 Dec 2012 - 15:20 - Equities - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: